Colin Sandercock serves as Executive at Cue Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Colin Sandercock has executed 12 insider transactions totaling $917.6K, demonstrating a bearish approach to their equity position. Their most recent transaction on Aug 5, 2020 involved selling 13,274 shares valued at $265.5K.
Colin Sandercock currently holds 17,125 shares of Cue Biopharma, Inc. (CUE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Colin Sandercock has been a net seller of CUE stock. They have purchased $252.1K and sold $665.5K worth of shares.
Colin Sandercock's most recent insider trade was on Aug 5, 2020, when they sold 13,274 shares at $20.00 per share.
Get notified when new Form 4 filings are submitted
| $7.50 |
| Discretionary |
| Aug 5, 2020 | CUE | $100.3K | Option Exercise | 13,374 | $7.50 | Discretionary |
| Aug 5, 2020 | CUE | $267.5K | Sale | 13,374 | $20.00 | Discretionary |
| Aug 4, 2020 | CUE | $4.0K | Sale | 201 | $20.05 | Discretionary |
| Aug 4, 2020 | CUE | $1.5K | Option Exercise | 201 | $7.50 | Discretionary |
| Aug 3, 2020 | CUE | $48.2K | Option Exercise | 6,425 | $7.50 | Discretionary |
| Aug 3, 2020 | CUE | $128.5K | Sale | 6,425 | $20.00 | Discretionary |
| Jun 10, 2019 | CUE | $118.7K | Purchase | 15,025 | $7.90 | Discretionary |
| Jun 10, 2019 | CUE | $118.5K | Purchase | 14,938 | $7.93 | Discretionary |
| Jun 7, 2019 | CUE | $735 | Purchase | 100 | $7.35 | Discretionary |
| Jun 6, 2019 | CUE | $14.2K | Purchase | 2,000 | $7.10 | Discretionary |